Jpmorgan Chase & CO Icad Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Icad Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 61 shares of ICAD stock, worth $96. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 64 4.69%

Holding current value

$96

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1.19 - $1.74 $3 - $5	-3 Reduced 4.69%	61 $0
Q2 2024 Aug 12, 2024	SELL	$1.28 - $1.9 $1,278 - $1,898	-999 Reduced 93.98%	64 $0
Q1 2024 May 10, 2024	BUY	$1.35 - $2.27 $1,435 - $2,413	1,063 New	1,063 $1,000
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.63 $2 - $3	2 New	2 $0
Q2 2022 Aug 11, 2022	SELL	$3.02 - $4.56 $7,577 - $11,441	-2,509 Reduced 24.44%	7,758 $31,000
Q1 2022 May 11, 2022	BUY	$3.92 - $7.48 $7,350 - $14,025	1,875 Added 22.34%	10,267 $46,000
Q3 2021 Nov 12, 2021	BUY	$10.11 - $17.56 $84,843 - $147,363	8,392 New	8,392 $90,000

Others Institutions Holding ICAD

# of Institutions

Shares Held

5.45M

Call Options Held

3.6K

Put Options Held

14.6K

View Full List

About ICAD INC

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $40M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

More about ICAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Icad Inc Transaction History